Cytosolic Nuclease TREX1 Regulates Oligosaccharyltransferase Activity Independent of Nuclease Activity to Suppress Immune Activation

Immunity
Maroof HasanNan Yan

Abstract

TREX1 is an endoplasmic reticulum (ER)-associated negative regulator of innate immunity. TREX1 mutations are associated with autoimmune and autoinflammatory diseases. Biallelic mutations abrogating DNase activity cause autoimmunity by allowing immunogenic self-DNA to accumulate, but it is unknown how dominant frameshift (fs) mutations that encode DNase-active but mislocalized proteins cause disease. We found that the TREX1 C terminus suppressed immune activation by interacting with the ER oligosaccharyltransferase (OST) complex and stabilizing its catalytic integrity. C-terminal truncation of TREX1 by fs mutations dysregulated the OST complex, leading to free glycan release from dolichol carriers, as well as immune activation and autoantibody production. A connection between OST dysregulation and immune disorders was demonstrated in Trex1(-/-) mice, TREX1-V235fs patient lymphoblasts, and TREX1-V235fs knock-in mice. Inhibiting OST with aclacinomycin corrects the glycan and immune defects associated with Trex1 deficiency or fs mutation. This function of the TREX1 C terminus suggests a potential therapeutic option for TREX1-fs mutant-associated diseases.

References

Feb 7, 2001·Proceedings of the National Academy of Sciences of the United States of America·D ChuiJ Marth
Jul 16, 2004·Molecular and Cellular Biology·Masashi MoritaDeborah E Barnes
Aug 30, 2008·Cell·Daniel B StetsonRuslan Medzhitov
Sep 23, 2008·The Journal of Biological Chemistry·Duane A LehtinenFred W Perrino
Oct 22, 2008·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Kevin L TaylorDaniel J Lindner
May 28, 2009·Journal of Cell Science·Richard J BodnarAlan Wells
Nov 21, 2009·Proceedings of the National Academy of Sciences of the United States of America·Tatsuya SaitohShizuo Akira
Jul 9, 2011·Molecular Biology of the Cell·Ningguo GaoMark A Lehrman
Jan 15, 2013·Current Opinion in Immunology·Christian K HolmKatherine A Fitzgerald
Apr 8, 2015·Proceedings of the National Academy of Sciences of the United States of America·Jessica L GrievesFred W Perrino

❮ Previous
Next ❯

Citations

Sep 18, 2015·Immunity·Winfried Barchet, Thomas Zillinger
Dec 23, 2015·Annals of Neurology·Ivana VodopivecJohn H Stone
Apr 18, 2016·Current Opinion in Cell Biology·Natalia CherepanovaReid Gilmore
Jun 30, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Maroof Hasan, Nan Yan
Sep 7, 2016·Medical Mycology·Amelia BercussonDarius Armstrong-James
Sep 9, 2016·Brain : a Journal of Neurology·Anine H StamMichel D Ferrari
Oct 11, 2016·Chemical Communications : Chem Comm·Luiza I HernandezFrank J Hernandez
Nov 26, 2016·Nature Communications·RaeAnna WilsonSudarshan Anand
Feb 2, 2017·Annual Review of Immunology·John T CrowlDaniel B Stetson
May 8, 2016·Cephalalgia : an International Journal of Headache·Shih-Pin ChenKatharina Eikermann-Haerter
Feb 2, 2018·Wellcome Open Research·Sarah McGlassonDavid P J Hunt
Mar 25, 2016·The EMBO Journal·Matteo Gentili, Nicolas Manel
Aug 2, 2019·The Journal of Immunology : Official Journal of the American Association of Immunologists·Nobumasa SodaTakashi Fujita
Jan 11, 2017·Proceedings of the National Academy of Sciences of the United States of America·Maroof HasanNan Yan
Mar 9, 2017·Headache·Heidi G Sutherland, Lyn R Griffiths
Jun 7, 2020·The Journal of Headache and Pain·Irene de BoerArn M J M van den Maagdenberg
May 6, 2017·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Nan Yan
Jul 31, 2019·Nature Reviews. Genetics·Mona MotwaniKatherine A Fitzgerald
Sep 6, 2018·Proceedings of the National Academy of Sciences of the United States of America·Hua LuMark A Lehrman
May 17, 2019·Current Neuropharmacology·Anisa Dehghani, Hulya Karatas
Nov 10, 2020·International Immunology·Hideo OnizawaTakashi Fujita
Dec 1, 2020·Multiple Sclerosis and Related Disorders·Jonika WeerasekareB Mark Keegan
Jan 22, 2021·Molecular Cell·Lisa MohrJohn Maciejowski
Mar 21, 2020·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·Bruce E EllerinJoseph T Martins
Jul 3, 2020·DNA Repair·Sean R SimpsonFred W Perrino
Mar 23, 2021·International Reviews of Immunology·Feng LinChunfu Zheng
Apr 16, 2021·Frontiers in Immunology·Mona MotwaniKatherine A Fitzgerald
Apr 20, 2021·Frontiers in Immunology·Wayne O HemphillFred W Perrino
Aug 7, 2021·Biochimica Et Biophysica Acta. General Subjects·Matthew P Wilson, Gert Matthijs
Oct 15, 2021·The Journal of Cell Biology·Lucia Morgado-Palacin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Basal Ganglia Cerebrovascular Disease

Basal ganglia cerebrovascular disease is a condition where the blood vessels in the basal ganglia are damaged or malfunction. Discover the latest research on basal ganglia cerebrovascular disease here.